|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, related party | ||||||||||||||||||||
| Short-term notes receivable from related party | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| NON-CURRENT ASSETS | ||||||||||||||||||||
| Investment in unconsolidated entities | ||||||||||||||||||||
| Option to purchase equity securities in related party | ||||||||||||||||||||
| Bismarck exploration license | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Right of use - operating leases | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Total non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Operating lease liability, current portion | ||||||||||||||||||||
| Forward contract liability | ||||||||||||||||||||
| Put option liability | ||||||||||||||||||||
| Loans payable, current portion | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Loans payable | ||||||||||||||||||||
| Debt derivative liabilities | ||||||||||||||||||||
| Warrant liabilities | ||||||||||||||||||||
| Litigation financing | ||||||||||||||||||||
| Deferred contract liability | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| Preferred stock - $0.0001 par value; 24,984,166 shares authorized; none issued and outstanding | ||||||||||||||||||||
| Common stock - $0.0001 par value; 75,000,000 shares authorized; 58,691,389 and 55,771,913 issued and outstanding 55,771,913 issued and outstanding | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' deficit before non-controlling interest | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||||
| Total liabilities and stockholders' deficit | ||||||||||||||||||||
Loading...
